Breast Cancer

A triple-negative breast cancer (TNBC) survivor, Latasha Jordan, considers the positive impact her support network has had on her treatment; and Aditya Bardia, M.D., MPH, emphasizes the importance of social support systems for patients with TNBC.

Latasha Jordan discusses her experience in a clinical trial with sacituzumab govitecan and comments on the side effects she experienced as well as the overall impact on her quality of life.

An expert oncologist highlights the importance of discussing clinical trial options with patients and comments on the recent FDA approval of sacituzumab govitecan in triple-negative breast cancer based on the ASCENT 3 trial.

A patient with triple-negative breast cancer, Latasha Jordan, reflects on the mental and emotional challenges she faced when she learned of her disease progression and shares her positive experience with physician referral thereafter.

A leader in breast oncology and a triple-negative breast cancer survivor discuss the role of active surveillance for post-surgical disease progression and emphasize the importance of support from health care providers after recurrence.

Aditya Bardia, M.D., MPH, and triple-negative breast cancer survivor, Latasha Jordan, discuss the importance of shared decision-making when considering mastectomy or lumpectomy and radiation for triple-negative breast cancer.

Latasha Jordan discusses her experience with neoadjuvant chemotherapy, and an expert in the management of breast cancer, Aditya Bardia, M.D., MPH, reviews common side events associated with systemic treatment.

"There is a ferocious fire that makes me restless," writes a two-time cancer survivor in a poem about her experiences with breast cancer.

In this episode of the “CURE® Talks Cancer” podcast, the hosts of the ‘Stage 4 Clinger’ podcast share the story of their cancer and caregiver journeys and how it led to the conception of their podcast.

A woman writes about the feeling of ambivalence that comes with each milestone in the treatment journey for her breast cancer.

A breast cancer survivor lists 5 steps that she will take to get her health back on track.

Knowing they’ve inherited a genetic mutation for stomach or breast cancer gives patients the power to plan ahead.

A caregiver writes about her daughter’s breast cancer odds. “One of the most difficult things I deal with on a daily basis is realizing that I didn’t have to say goodbye to my child because of luck,” she writes.

Initiative Spurred by New Report Detailing Systemic Racism and Barriers to Care in the 10 Metro Areas in the U.S. Experiencing Greatest Disparities

A woman living with metastatic breast cancer writes a poem about her reality.

A woman dedicates a poem to the experience of meeting a fellow breast cancer survivor.

Articles containing misinformation on social media sites like Facebook and Twitter were more likely to be shared and liked than those with accurate information.

The Major Histocompatibility Complex Class II protein has potential to predict immunotherapy benefit in two types of breast cancer.

The approval of the immunotherapy agent “has the potential to change the treatment paradigm” in high-risk, early-stage TNBC.

A breast cancer survivor writes a poem about feeling adrift after treatment.

“My stories are my trail of crumbs leading back to my heart and my innermost thoughts,” writes a woman living with metastatic breast cancer.

A patient reflects on the comfort and grief within the world of metastatic breast cancer.

A modeling study demonstrated that breast cancer mortality may increase by 0.52% by 2030, but effects of delays during the COVID-19 pandemic may be mitigated by making up screenings sooner than later.

A hard-charging executive felt lost after surviving cancer because she didn’t fit into her old life. But, she says, “cancer changed my life, so I changed my world.”

African American women with benign ethnic neutropenia had clinical benefit with Ibrance (palbociclib) in combination with endocrine therapy to treat advanced breast cancer.